| Literature DB >> 21526216 |
Nicola A G Meenan1, Graeme Ball, Krystyna Bromek, Dušan Uhrín, Alan Cooper, Malcolm W Kennedy, Brian O Smith.
Abstract
BACKGROUND:Entities:
Mesh:
Substances:
Year: 2011 PMID: 21526216 PMCID: PMC3079579 DOI: 10.1371/journal.pntd.0001040
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Lipid binding by recombinant ABA-1A before and after removal of resident ligands.
Comparison of the fluorescence enhancement of the fatty acid probe, DAUDA, upon binding to recombinant (r)ABA-1A before and after removal of contaminating ligand(s) by reverse phase chromatography. Fluorescence emission spectra of DAUDA (1.39 µM, λexc = 345 nm) upon additions of increasing concentrations of (A) rABA-1A, and (B) RP-ABA-1A, plotted on the same scale for comparison. The inset shows the increase in DAUDA fluorescence intensity at 475 nm with increasing concentrations of (circles) rABA-1A and (black squares) RP-ABA-1A under identical experimental conditions. Estimated KD for DAUDA binding to RP-ABA-1A is 0.11 (±0.03) µM.
Figure 2Reduced thermal stability of recombinant ABA-1A upon removal of resident ligand(s).
Differential scanning calorimetry (DSC) data showing the higher thermal stability of rABA-1A compared to the same protein (RP-ABA-1A) after treatment to remove endogenous ligands. This is consistent with the presence of bound endogenous ligands stabilizing the native conformation of the recombinant protein.
Structural statistics for the 20 lowest energy structures.
| Ensemble | Closest-to-mean | |
| Total NOE restraints | 4242 | |
| Ambiguous | 2173 | |
| Unambiguous/assignable | 2069 | |
| Intra-residue | 1046 | |
| Inter-residue | 1013 | |
| Sequential (| | 457 | |
| Non-sequential (| | 566 | |
| Total RDC restraints | 247 | |
| 1DNH | 71 | |
| 1DNC′ | 70 | |
| 1DC′Cα | 66 | |
| 1DCαHα | 40 | |
| Hydrogen bonds | 25 | |
| Coordinate r.m.s.d (Å) | ||
| Backbone heavy atoms | 0.575 | 0.388 |
| All heavy atoms | 0.963 | 0.817 |
| Parameter r.m.s.d from idealised geometry (mean and s.d.) | ||
| Bond lengths (Å) | 0.00435±8.8×10−5 | 0.0043 |
| Bond angles (°) | 0.663±0.015 | 0.642 |
| Impropers (°) | 2.18±0.078 | 2.07 |
| Dihedrals (°) | ||
| Violations (mean and s.d.) | ||
| Distance restraint violation (Å) | 0.033±0.007 | 0.031 |
| RDC Q factor | 0.122±0.005 | 0.115 |
| Ramachandran statistics (%) | ||
| Most favoured | 90.1 | 93.4 |
| Additionally allowed | 9.2 | 5.7 |
| Generously allowed | 0.4 | 0.0 |
| Disallowed | 0.3 | 0.8 |
Residues 4–126.
To the unbiased mean structure.
Figure 3The nuclear magnetic resonance structure of ABA-1A in solution.
(A) A stereo plot (wall-eyed) depicting the 20 lowest energy structures (from a total of 100) superimposed on the backbone heavy atoms of residues 4–126. (B, C, D) Three cartoon views (A and E rotated 180° about the y-axis and 90° about the x-axis with respect to (B) of the representative structure of ABA-1A with a color progression from blue (N-terminus) to red (C-terminus). (C) Enlargements of the wide helical turn at the end of α-helix A (upper inset) and the local environment of the absolutely conserved position Trp15 of NPAs (lower inset). Figures prepared using PyMol.
Figure 4ABA-1A's ligand binding cavities.
Molecular surfaces of the atoms lining the ligand binding cavities (probe radius 1.4 Å, cavities truncated at 3 probe radii) coloured by contact potential (blue, positive, graded through white, apolar, to red, negative). (A) Ribbon representation of ABA-1A with the binding cavities added, oriented with the N-terminal domain to the right as in Figure 3B. (B and C) The cavities in the same orientation but enlarged and with the residues lining the cavities displayed as sticks, illustrating the dominant apolarity of the cavities and the cluster of positively charged sidechains at the entrance of Cavity II. (D and E). The cavities rotated 180° about the vertical axis. Note that Trp15 does not contribute to any cavity surface.
Figure 5NMR evidence for ligand binding by rABA-1A.
A) Backbone amide chemical shift perturbation (√[|δ1H|2+(0.2|δ15N|)2]) reporting on changes in structure between different forms of ABA-1A: recombinant ABA-1A purified from E. coli (rABA-1A); rABA-1A saturated with oleic acid; rABA-1A stripped of resident ligand(s) by reverse phase chromatography (RP-ABA-1A); and RP-ABA-1A saturated with oleic acid. Saturation of either rABA-1A or RP-ABA-1A with oleic acid gives rise to essentially identical backbone amide chemical shifts and therefore structures. Compared with the oleic acid bound form, rABA-1A has different shifts in its C-terminal half indicating that cavity II is not occupied, or occupied by a different ligand in this form. In contrast RP-ABA-1A displays shifts in both N-and C-termini implying that both cavites are empty in this form. B) 15N HSQC spectra of RP-ABA-1A, rABA-1A and RP-ABA-1A saturated with oleic acid.
Figure 6ABA-1A structure and sequence support ancestral gene duplication.
A) Structure-based sequence alignment of N- and C-terminal halves of ABA-1A. B) and C) 180° rotated views of a superposition of the N- and C-terminal halves of ABA-1A.